With stable sales results and a strengthened position on the domestic pharmaceutical market, “Replek AD Skopje” starts 2026. During the first quarter of this year, the company achieved total sales in the Pharmacy segment of 7.2 million euros, with the domestic market recording a significant growth of 20%. At the Shareholders’ Assembly held at the beginning of April, a decision was adopted to increase the dividend by 25%, and all other proposed decisions were unanimously adopted, which is a confirmation of the shareholders’ confidence in the company’s management strategy.
Of the total sales, five million euros were realised on foreign markets, while 2.2 million euros were realised on the domestic market. This significant growth in the domestic market of 20% is the result of the increased demand for some of the key product lines, as well as the continuous strengthening of the company’s market position, which further confirms the trust of consumers and partners.
“The achieved business results in the first quarter confirm the stability of our operations, with the growth of the domestic market particularly encouraging us. The double-digit growth rate is the result of the continuous improvement of the portfolio, investments in innovations, modernisation of production capacities, as well as strengthening relations with partners and patients. We remain strongly committed to foreign markets, increasing exports and conquering new markets. The decision to increase the dividend is a confirmation of the stable financial position of “Replek” and our commitment to creating strong value for shareholders,” said Dushan Pecovski, CEO of “Replek”.
During the first quarter, some of the export activities took place with a changed dynamic, primarily as a result of the global challenges in the supply chains, which in combination with geopolitical factors led to the postponement of some of the planned deliveries towards the beginning of the second quarter and was the reason for a slight decrease in sales abroad by about eight percent. At the same time, the demand in the key export markets remains stable, and the company continues to implement the agreed activities in accordance with the established dynamics. Export markets continue to have a dominant share of about 75% in total revenues, while the domestic market participates with approximately 25%, which ensures stability and diversification of revenues.
This year, Replek shareholders will receive a dividend in the gross amount of 500 denars per share, which is an increase of 25% compared to the previous year and is above the level envisaged by the dividend policy. This, along with all other proposed decisions by the company’s Management Board, were adopted unanimously by the shareholders, which is a clear confirmation of their confidence in the company’s strategy and management. The company continues to implement its long-term growth strategy and will remain committed to expanding its presence in international markets, by strengthening its regulatory presence through new registration procedures in those markets. Focus will also be placed on the development of new products, improving production capacities and continuous modernisation, as well as digitalization and optimisation of business processes. All further activities will aim to ensure sustainable growth in revenues and profitability in the medium and long term, as well as further strengthening the company’s competitive position.